Advertisement

Journal of Neuro-Oncology

, Volume 76, Issue 2, pp 175–183 | Cite as

Definition and Diagnostic Implications of Gemistocytic Astrocytomas: A Pathological Perspective

  • Tarik Tihan
  • Poonam Vohra
  • Mitchel S. Berger
  • G. Evren Keles
Clinical Study

Summary

Gemistocytic astrocytoma still continues to be enigmatic; both in terms of definition and prognostic implications. The major issue of contention has been the clinical relevance of this pathological entity. The currently accepted definition of gemistocytic astrocytoma requires 20% or more gemistocytes, and considers the neoplasm as a diffuse astrocytoma, which is a WHO grade II tumor. Some suggest that gemistocytic morphology should be considered as evidence of a higher grade astrocytoma. However, there is no consensus on the percentage of gemistocytes associated with a worse prognosis than otherwise expected. Given the reported cases and series, it is not clear that this morphology portends a more aggressive biology when all else is equal. There is still a need for studies with sufficient numbers of well-matched gemistocytic and non-gemistocytic astrocytic neoplasms to decide whether upgrading a tumor with ‘significant’ number of gemistocytes is justifiable. This article presents a critical review of the existing studies and a brief mention of our experience from a pathological perspective.

Keywords

astrocytoma classification gemistocytic glioma pathology review 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kleihues, P, Cavenee, WKe 2000Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of TumoursIARC PressLyonGoogle Scholar
  2. 2.
    Kros, JM, Waarsenburg, N, Hayes, DP, Hop, WC, Dekken, H 2000Cytogenetic analysis of gemistocytic cells in gliomasJ Neuropathol Exp Neurol5967986PubMedGoogle Scholar
  3. 3.
    Abe, K, Hasegawa, H, Kobayashi, Y, Fujimura, H, Yorifuji, S, Bitoh, S 1990A gemistocytic astrocytoma demonstrated high intensity on MR images Protein hydration layerNeuroradiology321667PubMedGoogle Scholar
  4. 4.
    Krouwer, HG, Davis, RL, Silver, P, Prados, M 1991Gemistocytic astrocytomas: a reappraisalJ Neurosurg74399406PubMedGoogle Scholar
  5. 5.
    Okamoto, Y, Patre, PL, Burkhard, C, Horstmann, S, Jourde, B, Fahey, M, Schuler, D, Probst-Hensch, NM, Yasargil, MG, Yonekawa, Y, Lutolf, UM, Kleihues, P, Ohgaki, H 2004Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomasActa Neuropathol (Berl)1084956Google Scholar
  6. 6.
    Shaw, EG, Daumas-Duport, C, Scheithauer, BW, Gilbertson, DT, O’Fallon, JR, Earle, JD, Laws, ER,Jr., Okazaki, H 1989Radiation therapy in the management of low-grade supratentorial astrocytomasJ Neurosurg7085361PubMedGoogle Scholar
  7. 7.
    Westergaard, L, Gjerris, F, Klinken, L 1993Prognostic parameters in benign astrocytomasActa Neurochir (Wien)12317CrossRefGoogle Scholar
  8. 8.
    Nissl, F 1904Zur histopathologie der paralytischen RindenerkrankungHistol Histopathol Arb Grosshirn1315Google Scholar
  9. 9.
    Russell, DS, Rubinstein, LJ 1989Pathology of Tumors of the Nervous SystemWilliams & WilkinsBaltimore111114Google Scholar
  10. 10.
    Kleihues, P, Davis, RL, Ohgaki, H, Burger, PC, Westphal, MM, Cavenee, WK 2000Diffuse astrocytomaKleihues, PCavenee, WK eds. Pathology and Genetics of Tumors of the Nervous SystemIARC PressLyon2226Google Scholar
  11. 11.
    Zulch, KJ 1957The Astrocytomas, Brain Tumors, Their Biology and PathologySpringer Publishing CoNew York160167Google Scholar
  12. 12.
    Zulch, KJ 1979Histological Typing of Tumours of the Central Nervous SystemWorld Health OrganizationGenevaGoogle Scholar
  13. 13.
    Kleihues, P, Burger, PC, Scheithauer, BW 1993Histological Typing of Tumours of the Central Nervous SystemSpringer-VerlagBerlinGoogle Scholar
  14. 14.
    Elvidge, AR, Martinez-Coll, A 1956Long-term follow-up of 106 cases of astrocytom 1928–1939J Neurosurg1323043PubMedGoogle Scholar
  15. 15.
    Kosel, S, Scheithauer, BW, Graeber, MB 2001Genotype-phenotype correlation in gemistocytic astrocytomasNeurosurgery4818793discussion 193–4PubMedGoogle Scholar
  16. 16.
    Yang, HJ, Kim, JE, Paek, SH, Chi, JG, Jung, HW, Kim, DG 2003, The significance of gemistocytes in astrocytomaActa Neurochir (Wien)1451097103discussion 1103CrossRefGoogle Scholar
  17. 17.
    Naidoo, D 1955Gemistocytic astrocytoma: cytological observations on the rate of hydrolysis of some phosphoric acid estersActa Psychiatr Neurol Scand30499506PubMedGoogle Scholar
  18. 18.
    Hoshino, T, Wilson, BC, Ellis, WG 1975Gemistocytic astrocytes in gliomas. An autoradiographic studyJ Neuropathol Exp Neurol3426381PubMedGoogle Scholar
  19. 19.
    Giangaspero, F, Burger, PC 1983Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 casesCancer52232033PubMedGoogle Scholar
  20. 20.
    Kros, JM, Stefanko, SZ, Jong, AA, Vroonhoven, CC, Heul, RO, Kwast, TH 1991Ultrastructural and immunohistochemical segregation of gemistocytic subsetsHum Pathol223340PubMedGoogle Scholar
  21. 21.
    Burger, PC, Scheithauer, B, Vogel, FS 2002The Brain-Tumors, Surgical Pathology of the Nervous System and Its CoveringsChurchill LivingstonePhiladelphia160378Google Scholar
  22. 22.
    Ridley, A, Cavanagh, JB 1971Lymphocytic infiltration in gliomas: evidence of possible host resistanceBrain9411724PubMedGoogle Scholar
  23. 23.
    Boker, DK, Kalff, R, Gullotta, F, Weekes-Seifert, S, Mohrer, U 1984Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. GlioblastomaClin Neuropathol31437PubMedGoogle Scholar
  24. 24.
    Takeuchi, J, Barnard, RO 1976Perivascular lymphocytic cuffing in astrocytomasActa Neuropathol (Berl)3526571Google Scholar
  25. 25.
    Burger, PC, Vogel, FS, Green, SB, Strike, TA 1985Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implicationsCancer56110611PubMedGoogle Scholar
  26. 26.
    Watanabe, K, Tachibana, O, Yonekawa, Y, Kleihues, P, Ohgaki, H 1997Role of gemistocytes in astrocytoma progressionLab Invest7627784PubMedGoogle Scholar
  27. 27.
    Fulling, KH, Garcia, DM 1985Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic featuresCancer5592831PubMedGoogle Scholar
  28. 28.
    Perry, A, Jenkins, RB, O’Fallon, JR, Schaefer, PL, Kimmel, DW, Mahoney, MR, Scheithauer, BW, Smith, SM, Hill, EM, Sebo, TJ, Levitt, R, Krook, J, Tschetter, LK, Morton, RF, Buckner, JC 1999Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionCancer8667283CrossRefPubMedGoogle Scholar
  29. 29.
    Martins, DC, Stavale, JN, Malheiros, SM, Santiago, LH, Roman, LC, Aguiar, KC 2001[Fraction of gemistocytic astrocytes and immunoexpression of p53 protein in astrocytomas grade II and III (WHO)]Arq Neuropsiquiatr5992631PubMedGoogle Scholar
  30. 30.
    Kros, JM, Schouten, WC, Janssen, PJ, Kwast, TH 1996Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling studyActa Neuropathol (Berl)9199103Google Scholar
  31. 31.
    Ogashiwa, M, Nakadai, M, Asoh, Y, Maeda, T, Yokoyama, H, Takeuchi, K, Uchigasaki, S, Akai, K 1987[Morphological analysis of recurrent gliomas. Giant cell and gemistocytic cell formation]Neurol Med Chir (Tokyo)2727682CrossRefGoogle Scholar
  32. 32.
    Newcomb, EW, Bhalla, SK, Parrish, CL, Hayes, RL, Cohen, H, Miller, DC 1997Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene statusActa Neuropathol (Berl)9436975Google Scholar
  33. 33.
    Onda, K, Davis, RL, Wilson, CB, Hoshino, T 1994Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiformeActa Neuropathol (Berl)8758693Google Scholar
  34. 34.
    Lopes, MB, Altermatt, HJ, Scheithauer, BW, Shepherd, CW, VandenBerg, SR 1996Immunohistochemical characterization of subependymal giant cell astrocytomasActa Neuropathol (Berl)9136875Google Scholar
  35. 35.
    Powell, SZ, Yachnis, AT, Rorke, LB, Rojiani, AM, Eskin, TA 1996Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumorsAm J Surg Pathol20805CrossRefPubMedGoogle Scholar
  36. 36.
    Watanabe, K, Peraud, A, Gratas, C, Wakai, S, Kleihues, P, Ohgaki, H 1998p53 and PTEN gene mutations in gemistocytic astrocytomasActa Neuropathol (Berl)9555964Google Scholar
  37. 37.
    Reis, RM, Hara, A, Kleihues, P, Ohgaki, H 2001Genetic evidence of the neoplastic nature of gemistocytes in astrocytomasActa Neuropathol (Berl)1024225Google Scholar
  38. 38.
    Paulus, W, Grothe, C, Sensenbrenner, M, Janet, T, Baur, I, Graf, M, Roggendorf, W 1990Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumorsActa Neuropathol (Berl)7941823Google Scholar
  39. 39.
    Stefanik, DF, Rizkalla, LR, Soi, A, Goldblatt, SA, Rizkalla, WM 1991Acidic and basic fibroblast growth factors are present in glioblastoma multiforme and normal brainAnn N Y Acad Sci63847780PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Tarik Tihan
    • 1
    • 3
  • Poonam Vohra
    • 1
  • Mitchel S. Berger
    • 2
    • 3
  • G. Evren Keles
    • 2
    • 3
  1. 1.Department of PathologyUCSF School of MedicineSan FranciscoUSA
  2. 2.Neurological SurgeryUCSF School of MedicineSan FranciscoUSA
  3. 3.Brain Tumor Research CenterUCSF School of MedicineSan FranciscoUSA

Personalised recommendations